Abstract
The objective of this studies is to review clinical and laboratory features of lupus panniculitis. The authors report 3 cases of lupus profundus from a group of 70 lupus erythematosus. In both cases the lupus panniculitis presented as subcutaneous infiltrated and indurated nodules. The diagnosis was confirmed on clinical, histological and therapeutic data. The evolution is slow and is characterised by regression of the inflammatory lesions with treatment by antimalarial drugs. The lupus panniculitis has generally a favorable prognosis.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adolescent
-
Adult
-
Anti-Inflammatory Agents / administration & dosage
-
Anti-Inflammatory Agents / therapeutic use
-
Antimalarials / administration & dosage
-
Antimalarials / therapeutic use
-
Biopsy
-
Chloroquine / administration & dosage
-
Chloroquine / therapeutic use
-
Female
-
Fluorescent Antibody Technique
-
Humans
-
Lupus Erythematosus, Cutaneous* / diagnosis
-
Lupus Erythematosus, Cutaneous* / drug therapy
-
Lupus Erythematosus, Cutaneous* / pathology
-
Panniculitis, Lupus Erythematosus / diagnosis
-
Panniculitis, Lupus Erythematosus / drug therapy
-
Panniculitis, Lupus Erythematosus / pathology
-
Prednisone / administration & dosage
-
Prednisone / therapeutic use
-
Skin / pathology
-
Time Factors
Substances
-
Anti-Inflammatory Agents
-
Antimalarials
-
Chloroquine
-
Prednisone